After an 18-month investigation into the high cost of Gilead’s hepatitis C drug Sovaldi—initially listed at $84,000 for a course of treatment or $1,000 per pill—the Senate Finance Committee said the prices did not reflect the cost of research and development and that Gilead cared about “revenue” not “affordability and accessibility.” That sounds like an understatement. Sovaldi and the related pill Harvoni cost Medicare and Medicaid more than $5 billion in 2014, charged senators.
In 2008, the Texas attorney general’s office charged Risperdal maker Janssen (Johnson & Johnson’s psychiatric drug unit) with defrauding the state of millions “with [its] sophisticated and fraudulent marketing scheme,” to “secure a spot for the drug, Risperdal, on the state’s Medicaid preferred drug list and on controversial medical protocols that determine which drugs are given to […]
Sweet/bitter irony of this note that each congressman gets a quarter million dollars from big pharma as Nancy Regean who famously said: “Just Say No, to drugs” goes down.
but enough of somber irony, … back the the news: the Hulk Hogan rematch with Gawker, as the reality stars come to the fore of our sick media to avert attention for the Donald’s ‘hands’.